Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Good clinical update
View:
Post by DJDawg on May 30, 2023 11:14pm

Good clinical update

I'm happy with the swimmers plot data and the continued improvements in CR%.

What I am not skilled at is interpreting the financial situation. Can anyone with a finance background weigh in? I can't see how they would have much more than a few dollars left.
Comment by Yajne on May 31, 2023 12:05am
Agreed DJDawg. I'm no accountant but I just see "cash and cash equivalents of $365K as of March31" If so, and with two months gone since March31, I'm guessing that theyre running fairly tight on cash at the moment. Could a monumental NR be in the wings that would put warrants in the money? 
Comment by Yajne on May 31, 2023 12:40am
Further, in the MD&A the section "Going Concern, Capital Disclosures and Statement of Compliance" includes this line which I believe it was also included in the April MD&A: The Company is currently seeking new financing opportunities and intends to complete a financing round in Q2 2023.
Comment by Oilminerdeluxe on May 31, 2023 1:05am
Financing within a  month then. Good to have it over and done with. Onwards.
Comment by Oilminerdeluxe on May 31, 2023 3:22am
I seem to recall a video with Dr. Kulkarni where he said 30% would be *phenomenal" results.  So 33% is better than phenomenal. 
Comment by Lesalpes29 on May 31, 2023 6:59am
I know FDA has to be carefull before they approve any drug or ACT but for the suffering patients can they go a little faster and get BTD-AA in the coming weeks with the actual results? It seems to me it's really really slow. And we talk about a 'simple' process wiith good or very good results, even with 12 undertreated patients. Of course I don't understand everything because I' ...more  
Comment by socalbob on May 31, 2023 12:09am
Dawg this is not high finance. The cash situation has to be dire and must be addressed quickly.  The science might be great but it's going to take more money just to keep the lights on.  Hopefully, the solution won't be more and more dilution. All those existing warrants sitting out there have to be dealt with in any future JV or other buyout negotiations, and if more warrants ...more  
Comment by Alamir1111 on May 31, 2023 7:42am
So they filed the financial. On a 1.4 million expence you get to claim13% hst +gst which comes to around 180000$. Plus the 300000 +in the piggy ithink they good till early august
Comment by Sunvalley on May 31, 2023 9:08am
Just enough cash until the FDA approval kicks in if everything goes tickety-boo and if the application is filed immediatly. Then big pharma makes a deal with TLT with the necessary cash consideration up front and we are away to the races. We shall see how good RDW is at threading the needle from this point onwards. Possible but only a news release would confirm the foregoing.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250